Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic.

Weight loss drugs like Ozempic deliver more health benefits than expected.

Novo Nordisk launched "My Ozempic® Era" today, a national campaign which spotlights the longstanding Ozempic® patient ...

With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases ...

State DHS officials say new weight-loss drugs are driving up costs for Pennsylvania’s Medicaid program, likely leading to ...

"Studies have shown benefits in worsening kidney disease, heart failure and obstructive ... effect of a gaunt face (colloquially called "Ozempic face"), particularly in patients with less skin ...